Riber S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,741.00
1,978.00
586.00
2,476.00
7,352.00
2,975
Total Accounts Receivable
11,108.00
8,223.00
6,371.00
8,339.00
11,022.00
9,491
Inventories
9,724.00
8,412.00
7,139.00
7,456.00
9,939.00
15,559
Other Current Assets
252.00
124.00
139.00
81.00
132.00
181
Total Current Assets
22,825.00
18,737.00
14,235.00
18,352.00
28,445.00
28,206
Net Property, Plant & Equipment
8,355.00
5,187.00
4,732.00
4,593.00
4,933.00
4,800
Total Investments and Advances
105.00
233.00
292.00
290.00
-
237
Long-Term Note Receivable
-
-
-
-
247.00
-
Intangible Assets
3,608.00
3,911.00
3,698.00
2,897.00
2,011.00
1,930
Other Assets
16.00
2,576.00
2,495.00
38.00
35.00
607
Total Assets
34,909.00
30,644.00
25,452.00
26,830.00
37,480.00
38,321
ST Debt & Current Portion LT Debt
-
-
1,194.00
1.00
-
Accounts Payable
3,685.00
3,804.00
2,434.00
2,282.00
3,071.00
Income Tax Payable
-
-
-
-
242.00
Other Current Liabilities
4,930.00
4,575.00
5,940.00
7,991.00
13,653.00
Total Current Liabilities
8,615.00
8,379.00
9,568.00
10,274.00
16,966.00
Provision for Risks & Charges
782.00
721.00
630.00
600.00
724.00
Deferred Taxes
-
-
-
-
1,092.00
Total Liabilities
9,397.00
9,100.00
10,198.00
11,534.00
18,407.00
Common Equity (Total)
25,512.00
21,544.00
15,254.00
15,296.00
19,073.00
Total Shareholders' Equity
25,512.00
21,544.00
15,254.00
15,296.00
19,073.00
Total Equity
25,512.00
21,544.00
15,254.00
15,296.00
19,073.00
Liabilities & Shareholders' Equity
34,909.00
30,644.00
25,452.00
26,830.00
37,480.00

About Riber

View Profile
Address
31, rue Casimir PĂ©rier
Bezons Ile-de-France 95870
France
Employees -
Website http://www.riber.com/fr.html
Updated 07/08/2019
Riber SA is engaged in the manufacture and sale of molecular beam epitaxy systems. Its products include chemical vapour deposition systems; molecular beam epitaxy cell, sources, and accessories; copper indium gallium selenide; organic light-emitting diode displays; and automates & software. The company operates in the Research and Development, Effusion Cells and Sources segments.